$33.74
0.03[0.09%]
Last update: 9:06AM Get Real Time Here
Medifast Stock (NYSE:MED), Analyst Ratings, Price Targets, Predictions
Medifast Inc has a consensus price target of $90.67, established from looking at the 13 latest analyst ratings. The last 3 analyst ratings were released from DA Davidson, Stephens & Co., and DA Davidson on February 21, 2024, October 13, 2023, and August 8, 2023. With an average price target of $67.33 between DA Davidson, Stephens & Co., and DA Davidson, there's an implied 99.57% upside for Medifast Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
DA Davidson
Stephens & Co.
Jefferies
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Medifast
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/21/2024 | MED | Buy Now | Medifast | $33.74 | 18.55% | DA Davidson | Linda Bolton Weiser | $67 → $40 | Maintains | Neutral | Get Alert |
| 10/13/2023 | MED | Buy Now | Medifast | $33.74 | 143.03% | Stephens & Co. | Jim Salera | → $82 | Initiates | → Equal-Weight | Get Alert |
| 08/08/2023 | MED | Buy Now | Medifast | $33.74 | 137.11% | DA Davidson | Linda Bolton Weiser | $93 → $80 | Maintains | Neutral | Get Alert |
| 07/31/2023 | MED | Buy Now | Medifast | $33.74 | 175.64% | DA Davidson | Linda Bolton Weiser | $75 → $93 | Maintains | Neutral | Get Alert |
| 05/02/2023 | MED | Buy Now | Medifast | $33.74 | 110.43% | DA Davidson | Linda Bolton Weiser | $94 → $71 | Maintains | Neutral | Get Alert |
| 02/22/2023 | MED | Buy Now | Medifast | $33.74 | 178.6% | DA Davidson | Linda Bolton Weiser | $106 → $94 | Maintains | Neutral | Get Alert |
| 11/04/2022 | MED | Buy Now | Medifast | $33.74 | 214.17% | DA Davidson | Linda Bolton Weiser | $278 → $106 | Downgrade | Buy → Neutral | Get Alert |
| 08/04/2022 | MED | Buy Now | Medifast | $33.74 | 723.95% | DA Davidson | Linda Bolton Weiser | $352 → $278 | Maintains | Buy | Get Alert |
| 08/04/2022 | MED | Buy Now | Medifast | $33.74 | 344.58% | Jefferies | Stephanie Wissink | $345 → $150 | Downgrade | Buy → Hold | Get Alert |
| 06/02/2022 | MED | Buy Now | Medifast | $33.74 | 943.27% | DA Davidson | Linda Bolton Weiser | $341 → $352 | Maintains | Buy | Get Alert |
| 02/24/2022 | MED | Buy Now | Medifast | $33.74 | 910.67% | DA Davidson | Linda Bolton Weiser | $349 → $341 | Maintains | Buy | Get Alert |
| 11/08/2021 | MED | Buy Now | Medifast | $33.74 | 934.38% | DA Davidson | Linda Bolton Weiser | — | Maintains | Buy | Get Alert |
| 05/05/2021 | MED | Buy Now | Medifast | $33.74 | 1070.72% | DA Davidson | Linda Bolton Weiser | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Medifast (MED)?
The latest price target for Medifast (NYSE: MED) was reported by DA Davidson on February 21, 2024. The analyst firm set a price target for $40.00 expecting MED to rise to within 12 months (a possible 18.55% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Medifast (MED)?
The latest analyst rating for Medifast (NYSE: MED) was provided by DA Davidson, and Medifast maintained their neutral rating.
When was the last upgrade for Medifast (MED)?
There is no last upgrade for Medifast.
When was the last downgrade for Medifast (MED)?
The last downgrade for Medifast Inc happened on November 4, 2022 when DA Davidson changed their price target from $278 to $106 for Medifast Inc.
When is the next analyst rating going to be posted or updated for Medifast (MED)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medifast, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medifast was filed on February 21, 2024 so you should expect the next rating to be made available sometime around February 21, 2025.
Is the Analyst Rating Medifast (MED) correct?
While ratings are subjective and will change, the latest Medifast (MED) rating was a maintained with a price target of $67.00 to $40.00. The current price Medifast (MED) is trading at is $33.74, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.